|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2004-12-24
|
|
pubmed:abstractText |
Antibody responses against proteins located on the surface or in the apical organelles of merozoites are presumed to be important components of naturally acquired protective immune responses against the malaria parasite Plasmodium falciparum. However, many merozoite antigens are highly polymorphic, and antibodies induced against one particular allelic form might not be effective in controlling growth of parasites expressing alternative forms. The apical membrane antigen 1 (AMA1) is a polymorphic merozoite protein that is a target of naturally acquired invasion-inhibitory antibodies and is a leading asexual-stage vaccine candidate. We characterized the antibody responses against AMA1 in 262 individuals from Papua New Guinea exposed to malaria by using different allelic forms of the full AMA1 ectodomain and some individual subdomains. The majority of individuals had very high levels of antibodies against AMA1. The prevalence and titer of these antibodies increased with age. Although antibodies against conserved regions of the molecule were predominant in the majority of individuals, most plasma samples also contained antibodies directed against polymorphic regions of the antigen. In a few individuals, predominantly from younger age groups, the majority of antibodies against AMA1 were directed against polymorphic epitopes. The D10 allelic form of AMA1 apparently contains most if not all of the epitopes present in the other allelic forms tested, which might argue for its inclusion in future AMA1-based vaccines to be tested. Some important epitopes in AMA1 involved residues located in domain II or III but depended on more than one domain.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/15618180-10768987,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15618180-11115107,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15618180-11292751,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15618180-11399764,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15618180-11514442,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15618180-11832955,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15618180-12011004,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15618180-12117958,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15618180-12270711,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15618180-12438374,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15618180-12438375,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15618180-12595459,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15618180-12622324,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15618180-12686561,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15618180-12902400,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15618180-13880318,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15618180-14676185,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15618180-14688092,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15618180-15013785,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15618180-15049818,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15618180-15102786,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15618180-15271904,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15618180-1928564,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15618180-2436129,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15618180-2701947,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15618180-3194149,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15618180-7045680,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15618180-7810803,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15618180-7810805,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15618180-7838184,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15618180-8757869,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15618180-8784778,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15618180-8910611,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15618180-9353014,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15618180-9607037
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0019-9567
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
73
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
422-30
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:15618180-Adolescent,
pubmed-meshheading:15618180-Adult,
pubmed-meshheading:15618180-Age Factors,
pubmed-meshheading:15618180-Aged,
pubmed-meshheading:15618180-Alleles,
pubmed-meshheading:15618180-Animals,
pubmed-meshheading:15618180-Antibodies, Protozoan,
pubmed-meshheading:15618180-Antigens, Protozoan,
pubmed-meshheading:15618180-Child,
pubmed-meshheading:15618180-Child, Preschool,
pubmed-meshheading:15618180-Cross-Sectional Studies,
pubmed-meshheading:15618180-Epitopes,
pubmed-meshheading:15618180-Humans,
pubmed-meshheading:15618180-Infant,
pubmed-meshheading:15618180-Infant, Newborn,
pubmed-meshheading:15618180-Membrane Proteins,
pubmed-meshheading:15618180-Middle Aged,
pubmed-meshheading:15618180-Plasmodium falciparum,
pubmed-meshheading:15618180-Protozoan Proteins
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Allele specificity of naturally acquired antibody responses against Plasmodium falciparum apical membrane antigen 1.
|
|
pubmed:affiliation |
Division of Parasitology, MRC National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, United Kingdom. acortes@nimr.mrc.ac.uk
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
